Current Capabilities and Capacity of Ebola Treatment Centers in the United States
Item
Click for External Resource*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Current Capabilities and Capacity of Ebola Treatment Centers in the United States
Subject
Description
To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features.
Date
2016-03-01
Type
Citation
Herstein, J. J., P. D. Biddinger, C. S. Kraft, L. Saiman, S. G. Gibbs, A. B. Le, P. W. Smith, A. L. Hewlett and J. J. Lowe (2016). "Current Capabilities and Capacity of Ebola Treatment Centers in the United States." Infect Control Hosp Epidemiol 37(3): 313-318.
Abstract
OBJECTIVE: To describe current Ebola treatment center (ETC) locations, their capacity to care for Ebola virus disease patients, and infection control infrastructure features. DESIGN: A 19-question survey was distributed electronically in April 2015. Responses were collected via email by June 2015 and analyzed in an electronic spreadsheet. SETTING: The survey was sent to and completed by site representatives of each ETC. PARTICIPANTS: The survey was sent to all 55 ETCs; 47 (85%) responded. RESULTS: Of the 47 responding ETCs, there are 84 isolation beds available for adults and 91 for children; of these pediatric beds, 35 (38%) are in children's hospitals. In total, the simultaneous capacity of the 47 reporting ETCs is 121 beds. On the basis of the current US census, there are 0.38 beds per million population. Most ETCs have negative pressure isolation rooms, anterooms, and a process for category A waste sterilization, although only 11 facilities (23%) have the capability to sterilize infectious waste on site. CONCLUSIONS: Facilities developed ETCs on the basis of Centers for Disease Control and Prevention guidance, but specific capabilities are not mandated at this present time. Owing to the complex and costly nature of Ebola virus disease treatment and variability in capabilities from facility to facility, in conjunction with the lack of regulations, nationwide capacity in specialized facilities is limited. Further assessments should determine whether ETCs can adapt to safely manage other highly infectious disease threats.
Accessibility
pay online - or through cambridge journal subscription
Was this resource helpful?